atrasentan has been researched along with pyrrolidine in 1 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (pyrrolidine) | Trials (pyrrolidine) | Recent Studies (post-2010) (pyrrolidine) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 584 | 1 | 303 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, SA; Chiou, WJ; Dixon, DB; Henry, KJ; Hutchins, CW; Liu, G; Mantei, RA; Marsh, KC; Nguyen, B; Opgenorth, TJ; Sorensen, BK; Tasker, AS; von Geldern, TW; Winn, M; Wu-Wong, JR | 1 |
1 other study(ies) available for atrasentan and pyrrolidine
| Article | Year |
|---|---|
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivity.
Topics: Animals; Atrasentan; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Pyrrolidines; Rats; Receptor, Endothelin A; Structure-Activity Relationship | 1999 |